GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paxman AB (FRA:B0F) » Definitions » EV-to-EBITDA

Paxman AB (FRA:B0F) EV-to-EBITDA : 23.18 (As of May. 13, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Paxman AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Paxman AB's enterprise value is €62.75 Mil. Paxman AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €2.71 Mil. Therefore, Paxman AB's EV-to-EBITDA for today is 23.18.

The historical rank and industry rank for Paxman AB's EV-to-EBITDA or its related term are showing as below:

FRA:B0F' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7584.46   Med: 22.57   Max: 2179.24
Current: 23.49

During the past 7 years, the highest EV-to-EBITDA of Paxman AB was 2179.24. The lowest was -7584.46. And the median was 22.57.

FRA:B0F's EV-to-EBITDA is ranked worse than
67.08% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 16.55 vs FRA:B0F: 23.49

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), Paxman AB's stock price is €3.20. Paxman AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.037. Therefore, Paxman AB's PE Ratio for today is 86.49.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Paxman AB EV-to-EBITDA Historical Data

The historical data trend for Paxman AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paxman AB EV-to-EBITDA Chart

Paxman AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial 139.42 -437.37 407.84 49.27 22.03

Paxman AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.27 30.33 20.53 17.86 22.03

Competitive Comparison of Paxman AB's EV-to-EBITDA

For the Medical Devices subindustry, Paxman AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paxman AB's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Paxman AB's EV-to-EBITDA falls into.



Paxman AB EV-to-EBITDA Calculation

Paxman AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=62.748/2.707
=23.18

Paxman AB's current Enterprise Value is €62.75 Mil.
Paxman AB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paxman AB  (FRA:B0F) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Paxman AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.20/0.037
=86.49

Paxman AB's share price for today is €3.20.
Paxman AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.037.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Paxman AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Paxman AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Paxman AB (FRA:B0F) Business Description

Traded in Other Exchanges
Address
Pirgatan 13, Karlshamn, SWE, SE-374 35
Paxman AB is a Sweden based company engages in the development of PAXMAN Scalp Cooling System that is used to minimize hair loss in connection with chemotherapy treatment. The company offers a stand-alone, mobile electric cooling unit, which is a liquid-based cooling system that cools down the patient's scalp through the silicone hat. Geographically the company markets its product to Great Britain, Scandinavian countries, the Netherlands, Belgium, and Australia.

Paxman AB (FRA:B0F) Headlines

No Headlines